文献速递认知障碍与痴呆

轻度认知障碍与阿尔茨海默病中类淋巴系统MRI指标与淀粉样蛋白沉积及认知的关联

Association of MRI Indices of Glymphatic System With Amyloid Deposition and Cognition in Mild Cognitive Impairment and Alzheimer Disease.
PubMed 文献 · Neurology · 2022-12-12

基于阿尔茨海默病神经影像学倡议数据库,比较36例AD、44例MCI和31例健康对照的类淋巴系统MRI指标,并分析其与脑脊液生物标志物、PET SUVR及认知评分的关联。AD组血管周围间隙体积分数和自由水分数升高、ALPS指数降低,MCI组仅部分PVSVF升高;低ALPS指数和高FW-WM与较低的脑脊液Aβ42及较差认知相关。

要点

  • AD组总、白质和基底节PVSVF及FW-WM显著高于健康对照,ALPS指数显著低于健康对照。
  • MCI组仅总PVSVF和白质PVSVF显著高于健康对照。
  • 低ALPS指数与较低脑脊液Aβ42、FDG-PET摄取及多个认知域缺损相关。

核心结论

  • 本研究表明MCI和AD患者存在血管周围间隙相关MRI参数的变化,可能反映类淋巴系统受损。
  • 研究报告了AD中MRI参数与Aβ沉积、神经元改变及认知障碍之间的关联。

研究设计与样本

  • 研究纳入来自阿尔茨海默病神经影像学倡议数据库的36例AD患者、44例MCI患者和31例健康对照。
  • 比较三组的PVSVF、白质自由水分数(FW-WM)和沿血管周围间隙弥散指数(ALPS指数),并在MCI与AD合并亚组中分析MRI指标与脑脊液生物标志物、PET SUVR及认知评分的相关性。
  • 统计分析以年龄、性别、受教育年限和APOE状态作为混杂因素。

主要发现

  • AD组总、白质和基底节PVSVF显著高于健康对照(Cohen d=1.15-1.48;p<0.001)。
  • AD组FW-WM显著高于健康对照(Cohen d=0.73;p<0.05),ALPS指数显著低于健康对照(Cohen d=0.63;p<0.05)。
  • MCI组仅总PVSVF(Cohen d=0.99;p<0.05)和白质PVSVF(Cohen d=0.91;p<0.05)显著高于健康对照。
  • 低ALPS指数与较低脑脊液Aβ42(r s=0.41,p fdr=0.026)、较低FDG-PET摄取(r s=0.54,p fdr<0.001)及更差的多个认知域缺损相关。
  • 高FW-WM与较低脑脊液Aβ42(r s=-0.47,p fdr=0.021)及更差的认知表现相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The glymphatic system is a whole-brain perivascular network, which promotes CSF/interstitial fluid exchange. Alterations to this system may play a pivotal role in amyloid β (Aβ) accumulation. However, its involvement in Alzheimer disease (AD) pathogenesis is not fully understood. Here, we investigated the changes in noninvasive MRI measurements related to the perivascular network in patients with mild cognitive impairment (MCI) and AD. Additionally, we explored the associations of MRI measures with neuropsychological score, PET standardized uptake value ratio (SUVR), and Aβ deposition. METHODS: MRI measures, including perivascular space (PVS) volume fraction (PVSVF), fractional volume of free water in white matter (FW-WM), and index of diffusivity along the perivascular space (ALPS index) of patients with MCI, those with AD, and healthy controls from the Alzheimer's Disease Neuroimaging Initiative database were compared. MRI measures were also correlated with the levels of CSF biomarkers, PET SUVR, and cognitive score in the combined subcohort of patients with MCI and AD. Statistical analyses were performed with age, sex, years of education, and APOE status as confounding factors. RESULTS: In total, 36 patients with AD, 44 patients with MCI, and 31 healthy controls were analyzed. Patients with AD had significantly higher total, WM, and basal ganglia PVSVF (Cohen d = 1.15-1.48; p < 0.001) and FW-WM (Cohen d = 0.73; p < 0.05) and a lower ALPS index (Cohen d = 0.63; p < 0.05) than healthy controls. Meanwhile, the MCI group only showed significantly higher total (Cohen d = 0.99; p < 0.05) and WM (Cohen d = 0.91; p < 0.05) PVSVF. Low ALPS index was associated with lower CSF Aβ42 (r s = 0.41, p fdr = 0.026), FDG-PET uptake (r s = 0.54, p fdr < 0.001), and worse multiple cognitive domain deficits. High FW-WM was also associated with lower CSF Aβ42 (r s = -0.47, p fdr = 0.021) and worse cognitive performances. DISCUSSION: Our study indicates that changes in PVS-related MRI parameters occur in MCI and AD, possibly due to impairment of the glymphatic system. We also report the associations between MRI parameters and Aβ deposition, neuronal change, and cognitive impairment in AD.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Kamagata K, Andica C, Takabayashi K, et al. Association of MRI Indices of Glymphatic System With Amyloid Deposition and Cognition in Mild Cognitive Impairment and Alzheimer Disease. Neurology. 2022. PMID: 36123122. doi:10.1212/WNL.0000000000201300

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。